C. Fechtrup

Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction

Burkert Pieske, Rolf Wachter, Sanjiv J. Shah et al. · JAMA · 2021 · 161 citations · Full text

Medicine, Cardiology, Pharmacology +14

Plasma Lp(a) levels correlate with number, severity, and length-extension of coronary lesions in male patients undergoing coronary arteriography for clinically suspected coronary atherosclerosis.

T Budde, C. Fechtrup, Eileen Bösenberg et al. · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · 1994 · 103 citations

Medicine, Cardiology, Clinical Sciences +17

Prothrombin Activation Fragment 1 + 2 and Thrombin Antithrombin III Complexes in Patients with Angina Pectoris: Relation to the Presence and Severity of Coronary Atherosclerosis

Joachim Kienast, Simon G. Thompson, Claire Raskino et al. · Thrombosis and Haemostasis · 1993 · 76 citations

Medicine, Cardiology, Internal Medicine +13

Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study

Kausik K. Ray, Carlos Aguíar, Marcello Arca et al. · European Journal of Preventive Cardiology · 2024 · 70 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Antithrombin III and Fibrinogen as Predictors of Cardiac Events in Patients With Angina Pectoris

Simon G. Thompson, C. Fechtrup, E. Squire et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1996 · 62 citations · Full text

Medicine, Cardiology, Internal Medicine +12